Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis in Huntington's disease.

Miriam A Hickey1, Marie Françoise Chesselet

  • 1Department of Neurology, Reed Neurological Research Center, B114, The David Geffen School of Medicine at UCLA, 710 Westwood Plaza, 90095, Los Angeles, CA, USA.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|March 27, 2003
PubMed
Summary

Huntington's disease (HD) involves neuronal loss due to a mutant huntingtin gene. While apoptosis is implicated, the exact cell death mechanisms, particularly the role of proapoptotic proteins, are still being investigated for HD pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Mild cognitive impairment and cognitive aging.

Frontiers in behavioral neuroscience·2026
Same author

Early trigeminal and sensory impairment and lysosomal dysfunction in accurate models of Wolfram syndrome.

Experimental neurology·2024
Same author

Levodopa Impairs Lysosomal Function in Sensory Neurons In Vitro.

Biology·2024
Same author

Exploring the anti-inflammatory effects of curcumin encapsulated within ferritin nanocages: a comprehensive in vivo and in vitro study in Alzheimer's disease.

Journal of nanobiotechnology·2024
Same author

ER calcium depletion as a key driver for impaired ER-to-mitochondria calcium transfer and mitochondrial dysfunction in Wolfram syndrome.

Nature communications·2024
Same author

No Evidence of Sensory Neuropathy in a Traditional Mouse Model of Idiopathic Parkinson's Disease.

Cells·2024

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Huntington's disease (HD) is a fatal autosomal dominant disorder characterized by progressive motor, psychiatric, and cognitive decline.
  • The primary pathology involves selective degeneration of striatal medium spiny GABAergic neurons, with up to 95% loss in late stages.
  • The disease is caused by an expanded polyglutamine tract in the huntingtin gene, but the precise mechanism of selective neuronal death remains unclear.

Purpose of the Study:

  • To review the evidence supporting the role of apoptotic pathways and processes in the pathogenesis of Huntington's disease.
  • To explore how mutant huntingtin and proapoptotic proteins contribute to selective neuronal cell death in HD.
  • To discuss the potential significance of apoptosis-related processes over apoptosis itself in HD.

Related Experiment Videos

Main Methods:

  • Review of existing scientific literature and in vitro studies.
  • Analysis of evidence linking apoptotic pathways to mutant huntingtin.
  • Examination of theories on proapoptotic protein upregulation and huntingtin cleavage.

Main Results:

  • While direct evidence of apoptosis in HD is scarce, in vitro studies suggest a connection between mutant huntingtin and apoptotic pathways.
  • Upregulation of proapoptotic proteins may lead to huntingtin cleavage, generating toxic fragments that disrupt transcription.
  • Increased proapoptotic proteins might contribute to the slow, selective neuronal death observed in HD.

Conclusions:

  • Apoptosis-related processes, rather than apoptosis per se, are likely key contributors to Huntington's disease pathogenesis.
  • The interplay between mutant huntingtin, proapoptotic proteins, and transcriptional disruption offers a plausible mechanism for selective neurodegeneration in HD.
  • Further research into these apoptotic mechanisms is crucial for understanding and potentially treating Huntington's disease.